Table 3.
Comparison of frequency of patient characterisitcs between QFT-GIT positive vs. QFT-GIT negative
| Variable | QFT-GIT positive (N = 66) | QFT-GIT negative (N = 427) | P value |
|---|---|---|---|
| Male gender | 58 (87.9) | 324 (75.9) | 0.03 |
| Age (Median (25th, 75th)) | 33 (23, 44) | 31 (24, 42) | 0.52 |
| Age, by category | |||
| 18–29 | 28 (42.4) | 201 (47.1) | 0.54 |
| 30–39 | 14 (21.2) | 108 (25.3) | |
| 40–49 | 15 (22.7) | 72 (16.9) | |
| > 50 | 9 (13.6) | 46 (10.8) | |
| Hispanic ethnicity | 21 (39.6) | 97 (27.6) | 0.07 |
| Race | |||
| Black | 26 (39.4) | 201 (47.1) | 0.46 |
| White | 20 (30.3) | 121 (28.3) | |
| Other | 20 (30.3) | 105 (24.6) | |
| Non US born | 2 (3.1) | 16 (3.8) | 1.00 |
| Stayed in homeless shelter | 14 (21.2) | 57 (13.4) | 0.10 |
| >1 incarceration | 58 (89.2) | 358 (84.2) | 0.30 |
| Ever Injected Drugs | 16 (24.6) | 60 (14.2) | 0.03 |
| HIV + | 1 (1.5) | 12 (2.8) | 1.00 |
| Tested for HIV in past | 45 (68.2) | 307 (71.9) | 0.62 |
| Ever treated for TB | 3 (5.0) | 2 (0.5) | 0.02 |
| Vaccinated with BCG | 8 (14.3) | 50 (14.1) | 0.97 |
| Ever been exposed to TB | 4 (6.5) | 11 (2.8) | 0.14 |
| TST read | 47 (73.4) | 304 (71.2) | 0.71 |
| TST > 5 mm | 4 (8.5) | 4 (1.3) | 0.01 |
| TST > 10 mm | 2 (4.3) | 3 (1.0) | 0.14 |
| TB symptoms | |||
| Cough 3 weeks | 1 (1.6) | 1 (0.2) | 0.24 |
| Hemoptysis | 0 (0.0) | 1 (0.2) | 1.00 |
| Night sweats | 1 (1.6) | 3 (0.7) | 0.43 |
| Unexplained weight loss | 0 (0.0) | 2 (0.5) | 1.00 |
| Any of the above | 1 (1.5) | 6 (1.4) | 1.00 |
US United States of America, HIV human immunodeficiency virus, TB tuberculosis, BCG bacille Calmette-Guérin, TST tuberculin skin test